Renaissance Technologies LLC Has $31.90 Million Position in Core Scientific, Inc. $CORZ

Renaissance Technologies LLC grew its position in Core Scientific, Inc. (NASDAQ:CORZ) by 23.2% in the first quarter, HoldingsChannel.com reports. The fund owned 2,132,263 shares of the company’s stock after buying an additional 401,800 shares during the period. Renaissance Technologies LLC’s holdings in Core Scientific were worth $31,899,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of CORZ. Situational Awareness LP raised its holdings in shares of Core Scientific by 42.5% in the 4th quarter. Situational Awareness LP now owns 28,756,478 shares of the company’s stock valued at $418,694,000 after purchasing an additional 8,575,944 shares during the period. Value Aligned Research Advisors LLC acquired a new stake in Core Scientific in the 4th quarter valued at about $117,786,000. Vanguard Group Inc. grew its holdings in Core Scientific by 18.7% during the fourth quarter. Vanguard Group Inc. now owns 33,960,320 shares of the company’s stock worth $494,462,000 after purchasing an additional 5,359,710 shares during the period. Fifth Third Bancorp bought a new position in Core Scientific during the first quarter worth about $59,802,000. Finally, Clearline Capital LP increased its position in Core Scientific by 274.2% during the fourth quarter. Clearline Capital LP now owns 4,689,443 shares of the company’s stock worth $68,278,000 after buying an additional 3,436,127 shares during the last quarter.

Core Scientific Trading Up 0.0%

Shares of CORZ stock opened at $20.75 on Wednesday. The stock has a market cap of $6.60 billion, a P/E ratio of -18.20 and a beta of 5.50. Core Scientific, Inc. has a 1 year low of $12.60 and a 1 year high of $30.46. The stock has a 50 day simple moving average of $25.32 and a 200 day simple moving average of $20.77.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings data on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The business had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. Analysts forecast that Core Scientific, Inc. will post 0.08 EPS for the current year.

Insider Activity

In related news, insider Todd M. Duchene sold 10,000 shares of the firm’s stock in a transaction on Monday, July 20th. The stock was sold at an average price of $22.30, for a total value of $223,000.00. Following the transaction, the insider owned 1,999,101 shares in the company, valued at approximately $44,579,952.30. This trade represents a 0.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders sold 80,000 shares of company stock worth $2,025,400. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CORZ shares. B. Riley Financial upped their price objective on Core Scientific from $30.00 to $33.00 and gave the company a “buy” rating in a research note on Wednesday, May 27th. Lucid Cap Mkts upgraded Core Scientific to a “strong-buy” rating in a research note on Friday, June 12th. BTIG Research reissued a “buy” rating and set a $38.00 target price on shares of Core Scientific in a report on Tuesday. Jefferies Financial Group boosted their target price on Core Scientific from $24.00 to $37.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Finally, Freedom Capital upgraded Core Scientific to a “hold” rating in a research note on Monday, June 15th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Core Scientific currently has an average rating of “Moderate Buy” and an average target price of $30.39.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: AMD partnership creates significant long-term revenue potential. AMD will secure up to 2.5 gigawatts of Core Scientific data-center capacity for AI deployments. The initial 530-megawatt rollout across five sites is backed by 15-year agreements and could generate approximately $14 billion in potential base contracted revenue. AMD also received warrants to purchase 30 million CORZ shares at $23.47, with vesting tied to successful capacity deployment. Reuters AMD infrastructure partnership article
• Positive Sentiment: Colocation growth reinforces the AI pivot. Second-quarter revenue reached $164.2 million, while colocation revenue reportedly climbed to $136.7 million from $10.6 million a year earlier. The company said adjusted EBITDA was $41.1 million, suggesting improving operating performance despite reported accounting losses. Core Scientific second-quarter results
• Positive Sentiment: Analyst support and bullish options activity added momentum. Needham reaffirmed a Buy rating with a $29 price target, while BTIG maintained Buy with a $38 target. Call-option volume was approximately 55% above its average daily level, indicating increased speculative interest, though options activity is not a guarantee of future gains.
• Neutral Sentiment: Reported earnings contained conflicting signals. Core Scientific posted a $3.32-per-share quarterly GAAP loss, far below consensus, but another earnings measure cited by Zacks showed adjusted EPS of $0.18 versus expectations for a $0.02 loss. The GAAP deficit was reportedly driven largely by noncash warrant fair-value adjustments.
• Negative Sentiment: Execution, dilution and spending risks remain material. Core Scientific incurred approximately $797.5 million in quarterly capital expenditures to convert mining sites for high-density computing. The AMD warrants could dilute shareholders, while an insider’s sale of 10,000 shares and a recent KBW downgrade to Market Perform may temper enthusiasm.

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.